New Oxford Review Questions the Definitive Efficacy of Vaping as a Smoking Cessation Tool

Oxford University Press review finds vaping cessation success rates vary by study design, with lower efficacy seen in smokers actively trying to quit.

By: AXL Media

Published: May 1, 2026, 4:35 AM EDT

Source: Information for this report was sourced from EurekAlert!

The Persistent Challenge of Global Tobacco Addiction

Cigarette smoking remains the primary cause of preventable mortality worldwide, despite a vast majority of users expressing a desire to stop. In the United States, data from 2022 indicates that while nearly 68% of the 28.8 million adult smokers were interested in quitting, and over half made an attempt, the actual success rate hovered around a dismal 8.8%. Although the Food and Drug Administration has approved several cessation medications, such as varenicline and bupropion, the utilization of these clinical aids remains surprisingly low among the general population.

Analyzing the Rise of Nicotine Vape Products

Since 2010, the prevalence of nicotine vape products has grown steadily, reaching approximately 6% of the U.S. adult population by 2022. These electronic devices are most commonly used by current or former smokers, with a higher concentration of adoption found among younger demographics. This trend suggests that a significant number of individuals are turning to vaping as a potential alternative to traditional tobacco, often with the hope of reducing their dependency on combustible cigarettes through a less conventional method.

Discrepancies in National Tobacco Study Data

To investigate the conflicting reports on vaping efficacy, researchers conducted a narrative review of 38 studies utilizing the Population Assessment of Tobacco and Health (PATH) Study. This longitudinal data source provides a comprehensive look at tobacco use patterns in the United States over time. The investigators discovered that while 63.2% of these studies reported increased odds of quitting within a three year window, the remaining research found no such evidence. This inconsistency has fueled ongoing controversy within the public health community regarding the reliability of e-cigarettes as a medical aid.